MEP26708A - Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method - Google Patents

Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Info

Publication number
MEP26708A
MEP26708A MEP-267/08A MEP26708A MEP26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A
Authority
ME
Montenegro
Prior art keywords
coating
preparation
compound
inert
pharmaceutical oral
Prior art date
Application number
MEP-267/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada De Sustancias Activas S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP26708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada De Sustancias Activas S A filed Critical Liconsa Liberacion Controlada De Sustancias Activas S A
Publication of MEP26708A publication Critical patent/MEP26708A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MEP-267/08A 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method MEP26708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
MEP26708A true MEP26708A (en) 2010-06-10

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-267/08A MEP26708A (en) 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Country Status (31)

Country Link
US (1) US6737082B1 (sk)
EP (1) EP1103252B1 (sk)
JP (1) JP4190732B2 (sk)
KR (1) KR100572135B1 (sk)
AT (1) ATE234077T1 (sk)
AU (1) AU750730B2 (sk)
BG (1) BG65187B1 (sk)
BR (1) BR9912300A (sk)
CA (1) CA2337509C (sk)
CZ (1) CZ291938B6 (sk)
DE (1) DE69905905T2 (sk)
DK (1) DK1103252T3 (sk)
EE (1) EE04415B1 (sk)
ES (2) ES2157731B1 (sk)
HK (1) HK1037531A1 (sk)
HR (1) HRP20010128B1 (sk)
HU (1) HU228895B1 (sk)
IL (1) IL140910A (sk)
ME (1) MEP26708A (sk)
MX (1) MXPA01000681A (sk)
NO (1) NO320054B1 (sk)
NZ (1) NZ509886A (sk)
PL (1) PL194740B1 (sk)
PT (1) PT1103252E (sk)
RS (1) RS50063B (sk)
RU (1) RU2209628C2 (sk)
SK (1) SK283279B6 (sk)
TR (1) TR200100177T2 (sk)
UA (1) UA64009C2 (sk)
WO (1) WO2000004881A1 (sk)
ZA (1) ZA200101293B (sk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218662T3 (es) * 1996-01-31 2004-11-16 South Alabama Medical Science Foundation Preparaciones de alimento y vitaminas que contienen isomeros naturales de folatos reducidos.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DE60312635T3 (de) * 2003-01-14 2013-05-08 Cimex Pharma Ag Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
SI1438961T2 (sl) * 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
CN1822843B (zh) * 2003-07-17 2010-04-28 泰博特克药品有限公司 制备含有抗病毒药物颗粒的方法
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US8653083B2 (en) 2005-08-22 2014-02-18 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
JP2018520114A (ja) * 2015-05-25 2018-07-26 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． イソトレチノインの１日１回経口医薬組成物
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
JP7409302B2 (ja) * 2018-04-27 2024-01-09 Ｔｏｐｐａｎホールディングス株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
JP3391801B2 (ja) * 1996-05-20 2003-03-31 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 向上した生物学的利用性を有する抗菌性組成物
CA2255663C (en) * 1996-05-24 2002-08-20 Schering Corporation Antifungal composition with enhanced bioavailability
NZ333514A (en) * 1996-06-28 2000-05-26 Schering Corp Oral pharmaceutical composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
PT969821E (pt) 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Also Published As

Publication number Publication date
CA2337509C (en) 2005-12-27
PL345625A1 (en) 2002-01-02
RS50063B (sr) 2009-01-22
DK1103252T3 (da) 2003-07-14
BG65187B1 (bg) 2007-06-29
BG105282A (en) 2001-11-30
HRP20010128B1 (en) 2003-12-31
HUP0103708A3 (en) 2002-07-29
DE69905905T2 (de) 2004-03-04
AU4782199A (en) 2000-02-14
HUP0103708A2 (hu) 2002-02-28
DE69905905D1 (de) 2003-04-17
US6737082B1 (en) 2004-05-18
EE04415B1 (et) 2005-02-15
IL140910A0 (en) 2002-02-10
KR100572135B1 (ko) 2006-04-19
JP2002521323A (ja) 2002-07-16
IL140910A (en) 2004-03-28
HU228895B1 (en) 2013-06-28
EP1103252A1 (en) 2001-05-30
RU2209628C2 (ru) 2003-08-10
ATE234077T1 (de) 2003-03-15
MXPA01000681A (es) 2002-04-24
NO20010289L (no) 2001-03-07
TR200100177T2 (tr) 2001-07-23
HK1037531A1 (en) 2002-02-15
NO20010289D0 (no) 2001-01-17
EE200100041A (et) 2002-06-17
PL194740B1 (pl) 2007-06-29
CZ291938B6 (cs) 2003-06-18
KR20010070990A (ko) 2001-07-28
SK283279B6 (sk) 2003-05-02
EP1103252B1 (en) 2003-03-12
UA64009C2 (en) 2004-02-16
ES2157731B1 (es) 2002-05-01
CZ2001175A3 (en) 2001-05-16
YU3901A (sh) 2003-08-29
BR9912300A (pt) 2001-04-17
WO2000004881A1 (es) 2000-02-03
NO320054B1 (no) 2005-10-17
SK862001A3 (en) 2001-08-06
AU750730B2 (en) 2002-07-25
PT1103252E (pt) 2003-07-31
JP4190732B2 (ja) 2008-12-03
HRP20010128A2 (en) 2002-12-31
ES2157731A1 (es) 2001-08-16
ZA200101293B (en) 2001-08-21
ES2194480T3 (es) 2003-11-16
NZ509886A (en) 2002-09-27
CA2337509A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
MEP26708A (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
DK1059848T3 (da) Dragéret tyggegummi, fremgangsmåde til fremstilling hraf samt anvendelse af et eller flere aktive stoffer i fast form
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
HRP20010463B1 (en) Controlled release galantamine composition
DK2332523T3 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
DE69510333D1 (de) Synergetische termitizide zusammensetzung aus pyrethroid und n-phenyl-pyrazol
JP2003512395A5 (sk)
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
DE60040674D1 (de) Silber enthaltende zusammensetzungen, geräte und verfahren zu deren herstellung
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
UA95993C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
BG104193A (en) Peroral pharmaceutical preparation including a compound with antiulcerous activity, and method for its preparation
DK1124539T3 (da) Farmaceutisk formulering der omfatter omeprazol
FI93924B (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
WO2005027843A3 (en) Chronotherapeutic dosage forms
NO20033305D0 (no) Nytt filmbelegg
EP1177788A3 (en) Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture
TW200503616A (en) Process for the preparation of a pesticidal formulation